Sloan Simpson

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when Novartis AG publishes a filing, an earnings call transcript or a press release.

About Sloan Simpson

Sloan Simpson is recorded as Head of Investor Relations at Novartis AG (NVS). Sloan Simpson has spoken on 9 earnings calls across 1 company, most recently for Novartis AG on April 28, 2026. Novartis AG is classified in the Drug Manufacturers - General industry within the Healthcare sector.

Sloan Simpson on recent calls

“The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties, and other factors. These may cause actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements.”

Head of Investor Relations, Novartis Q1 2026 Results Release · April 28, 2026

“The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties, and other factors. These may cause actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements.”

Head of Investor Relations, Novartis AG Q4 FY2025 Earnings Call · February 4, 2026

“The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements.”

Head of Investor Relations, Novartis AG Q3 FY2025 Earnings Call · October 28, 2025

“The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements.”

Head of Investor Relations, Novartis AG Q2 FY2025 Earnings Call · June 30, 2025

“The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties, and other factors. These may cause actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements.”

Head of Investor Relations, Novartis AG Q1 FY2025 Earnings Call · March 31, 2025